Pediatric Cardiology

, Volume 38, Issue 5, pp 1004–1009 | Cite as

Lone Pediatric Atrial Fibrillation in the United States: Analysis of Over 1500 Cases

  • Iqbal El-Assaad
  • Sadeer G. Al-Kindi
  • Elizabeth V. Saarel
  • Peter F. Aziz
Original Article

Abstract

Little is known about lone atrial fibrillation (AF) in pediatrics and its risk factors due to low prevalence. We sought to determine risk factors and estimate recurrence rates in children with lone AF using a large clinical database. Using the Explorys clinical database, we retrospectively identified patients who were below 20 years of age at the time of their AF diagnosis. Patients with congenital heart disease, cardiomyopathy, prior open heart surgery, or thyroid disease were excluded. Out of 7,969,230 children identified, 1910 had AF and 1570 met the definition of lone AF. The prevalence of lone AF was 7.5 per 100,000 children. In comparison to young children (0–4 years), risk for lone AF increased with age (adjusted odds ratio (aOR) 1.2 [95% CI 0.9–1.5, P = 0.21] in those 5–9 years, aOR 1.7 [95% CI 1.3–2.1, P < 0.001] in those 10–14 years, and aOR 10.7 [95% CI 8.7–13.2, P < 0.001] in those 15–19 years). Risk of lone AF was also higher in males than females (aOR 1.7 [95% CI 1.5–1.9, P < 0.001]), and was higher in obese children (BMI ≥ 95th percentile) versus children with normal BMI (aOR 1.3 [95% CI 1.1–1.5], P < 0.001), but there was no difference between overweight (BMI = 85th–94th percentile) and normal (P = 0.14). One-month recurrence rate was 15%, and increased with age. In this large pediatric cohort, the prevalence of lone AF was low, but risk was higher in males and increased with age and obesity. Older children with lone AF had higher rates of recurrence.

Keywords

Lone atrial fibrillation Obesity Pediatrics Explorys Clinical database 

Supplementary material

246_2017_1608_MOESM1_ESM.tif (26 kb)
Supplementary material 1 (TIF 26 KB)

References

  1. 1.
    Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMedGoogle Scholar
  2. 2.
    Walsh EP, Cecchin F (2007) Arrhythmias in adult patients with congenital heart disease. Circulation 115:534–545CrossRefPubMedGoogle Scholar
  3. 3.
    Mills LC, Gow RM, Myers K, Kantoch MJ, Gross GJ, Fournier A, Sanatani S (2013) Lone atrial fibrillation in the pediatric population. Can J Cardiol 29:1227–1233CrossRefPubMedGoogle Scholar
  4. 4.
    Dublin S, French B, Glazer NL, Wiggins KL, Lumley T, Psaty BM, Smith NL, Heckbert SR (2006) Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 166:2322–2328CrossRefPubMedGoogle Scholar
  5. 5.
    Wang TJ, Parise H, Levy D, D’Agostino RB Sr, Wolf PA, Vasan RS, Benjamin EJ (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477CrossRefPubMedGoogle Scholar
  6. 6.
    Tedrow UB, Conen D, Ridker PM, Cook NR, Koplan BA, Manson JE, Buring JE, Albert CM (2010) The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study). J Am Coll Cardiol 55:2319–2327CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA 311:806–814CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Barlow SE, Expert C (2007) Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 120(Suppl 4):S164–S192CrossRefPubMedGoogle Scholar
  9. 9.
    Kaelber DC, Foster W, Gilder J, Love TE, Jain AK (2012) Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. JAMIA 19:965–972PubMedPubMedCentralGoogle Scholar
  10. 10.
    Maradey-Romero C, Prakash R, Lewis S, Perzynski A, Fass R. The 2011–2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther 2015.Google Scholar
  11. 11.
    Shanmugam VK, Fernandez S, Evans KK, McNish S, Banerjee AN, Couch KS, Mete M, Shara N. Postoperative wound dehiscence: predictors and associations. Wound Repair Regen 2015Google Scholar
  12. 12.
    Yurteri-Kaplan LA, Mete MM, St Clair C, Iglesia CB (2015) Practice patterns of general gynecologic surgeons versus gynecologic subspecialists for concomitant apical suspension during vaginal hysterectomy for uterovaginal prolapse. South Med J 108:17–22CrossRefPubMedGoogle Scholar
  13. 13.
    Pfefferle K, Gil K, Fening S, Dilisio M (2014) Validation study of a pooled electronic healthcare database: the effect of obesity on the revision rate of total knee arthroplasty. Eur J Orthop Surg Traumatol 24:1625–1628CrossRefPubMedGoogle Scholar
  14. 14.
    Radford DJ, Izukawa T (1977) Atrial fibrillation in children. Pediatrics 59:250–256PubMedGoogle Scholar
  15. 15.
    Ceresnak SR, Liberman L, Silver ES et al (2013) Lone atrial fibrillation in the young—perhaps not so “lone”? J Pediatr 162:827–831CrossRefPubMedGoogle Scholar
  16. 16.
    Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844CrossRefPubMedGoogle Scholar
  17. 17.
    Sciarra L, Rebecchi M, De Ruvo E, De Luca L, Zuccaro LM, Fagagnini A, Coro L, Allocca G, Lioy E, Delise P, Calo L (2010) How many atrial fibrillation ablation candidates have an underlying supraventricular tachycardia previously unknown? Efficacy of isolated triggering arrhythmia ablation. Europace 12:1707–1712CrossRefPubMedGoogle Scholar
  18. 18.
    Sauer WH, Alonso C, Zado E, Cooper JM, Lin D, Dixit S, Russo A, Verdino R, Ji S, Gersetendfeld EP, Callans DJ, Marchlinski FE (2006) Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification. Circulation 114:191–195CrossRefPubMedGoogle Scholar
  19. 19.
    Strieper MJ, Frias P, Fischbach P, Costello L, Campbell RM (2010) Catheter ablation of primary supraventricular tachycardia substrate presenting as atrial fibrillation in adolescents. Congenit Heart Dis 5:465–469CrossRefPubMedGoogle Scholar
  20. 20.
    January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Developed in collaboration with the Society f Thoracic Surgeons. J Am Coll Cardiol 64:1–76.CrossRefGoogle Scholar
  21. 21.
    Oyen N, Ranthe MF, Carstensen L, Boyd HA, Olesen MS, Olesen SP, Wohlfahrt J, Melbye M (2012) Familial aggregation of lone atrial fibrillation in young persons. J Am Coll Cardiol 60:917–921CrossRefPubMedGoogle Scholar
  22. 22.
    Roberts JD, Gollob MH (2010) Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 55:705–712CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2017

Authors and Affiliations

  • Iqbal El-Assaad
    • 1
  • Sadeer G. Al-Kindi
    • 2
  • Elizabeth V. Saarel
    • 3
  • Peter F. Aziz
    • 3
  1. 1.Department of PediatricsCleveland Clinic Children’sClevelandUSA
  2. 2.Harrington Heart and Vascular InstituteUniversity Hospitals Case Medical Center & Case Western Reserve UniversityClevelandUSA
  3. 3.Division of Pediatric CardiologyCleveland Clinic Children’s, Cleveland Clinic Lerner College of MedicineClevelandUSA

Personalised recommendations